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SUMMARY: We report here that human synovial cells stimulated by interleukin- 
la and interleukin-18 express mRNA for both IL-8 (neutrophil chemotactic 
peptide) and monocyte chemotactic protein. IL-1 stimulated synovial cells from 
both osteoarthritis and rheumatoid arthritis patients exhibited similar mRNA 
expression of interleukin-8 and monocyte chemotactic protein. A capacity to 
produce factors selectively chemotactic for neutrophils, lymphocytes and 
monocytes provides a mechanism whereby synovial cells can facilitate 
inflammatory arthritis. 0 1991 ‘kadem1c mess, inc. 
Joint inflammation in rheumatoid arthritis @A) is characterized by the 
presence of lymphocytes and monocyte-derived macrophages in a hyperplastic 
synovium, and polymorphonuclear leucocytes (PMN) in synovial fluid. The 
reasons why cells invade the synovium and synovial fluid and why synovial cells 
proliferate in RA patients have not been defined. Experimental evidence does 
indicate that products exported by monocytes, macrophages, lymphocytes and 
platelets help regulate synovial cell proliferation (1). More recently, factors 
specifically chemotactic for PMN (neutrophil activating peptide/interleukin-8) or 
monocytes (monocyte chemotactic proteinMCP) have been identified in several 
types of cells (2-6). In addition, supernatants from interleukin-1 (IL-I) stimulated 
human synovial cells in culture express an activity (PMN stimulating factor) that 
activates neutrophils, as assessed by increased PMN free calcium concentrations 
1 
To whom correspondence should be addressed. 
Abbreviations used: AA, arachidonic acid; DGLA, dihomogamma linolenic acid; 
EPA, eicosapentaenoic acid; IL-l, interleukin 1; IL-8, interleukin 8; MCP, 
monocyte chemotactic protein; OA, osteoarthritis; PMN, polymorphonuclear 
leucocytes; R4, rheumatoid arthritis. 
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(7). It was therefore of interest to determine whether synovial cells might be able to 
produce selective chemotactic factors. We report here that human synovial cells 
stimulated by IL-la and IL-18 express mRNA for both IL-8 and MCP. 
TERIALS AND METHODS 
. 
8movld Cdl Cd . Synovial tissue was obtained with the approval of the 
Human Experimentation Committee at the University of Pennsylvania, and with 
the cooperation of the Department of Pathology and Laboratory Medicine, from 
patients undergoing total knee arthroplasty. Tissue, obtained directly from the 
operating room to maintain sterility and cell viability, was rinsed with phosphate 
buffered saline , minced and placed in a trypsinizing flask with 20 ml of 10% 
trypsin (Flow Laboratories, McClean, VA) and versene. The flask was kept in a 
370C warm room and stirred for 90 min. Supernatant was collected, washed twice 
in RPMI-1640 (Gibco Laboratories, Grand Island, NY) with 10% fetal calf serum 
(FCS) and cells were counted. They were then incubated at a concentration of l-2 x 
106 cells/ml overnight for adherence. After 24 hr, the supernatants were collected 
and the adherent synovial cells were re-fed with RPMI-20% FCS. Cultures were 
allowed to grow to confluence, which usually required 7-10 days, and were then 
passaged. 
Svnovial Cell Stimulation: Cells from passage 2-8 were used for all experiments. 
Cells (0.5 - 1.0 x 106/n-$ were incubated overnight in 100 mm culture plates (Costar 
Cambridge, MA). Supernatants were harvested and adherent cells were washed 
twice with RPM1 without FCS. They were then stimulated with either 5 rig/ml 
human recombinant interleukin-la (rhIL-lo > or 1 rig/ml interleukin l-8 (rhIL-18) 
and allowed to incubate at 370C for 8 hr. Fatty acids (10 pg/ml) were added to 
selected cultures. Supernatants were harvested and frozen. Guanidine 
isothiocyanate (3 ml per plate) was added and the mixture frozen until Northern 
blot analysis for mRNA. 
mRNA Assessment: Total cellular RNA was extracted by modifying previously 
published methods (8). The total RNA extracts were thawed and homogenized. 
An equal volume of 100 mM tris, (pH 8.0) containing 1.0% SDS and 10 mM EDTA 
was added and the RNA extracted with chloroform-phenol. The RNA was 
separated by formaldehyde/l% agarose gels and transblotted to nitrocellulose. The 
baked blots were prehybridized and then hybridized with 32P-5’-end-labeled 30-mer 
oligonucleotide probe. The probes were complementary to either nucleotides 256- 
285 of published cDNA sequence for human monocyte chemotactic activity 
factor/monocyte chemoattractant protein or nucleotides 262-291 of a published 
cDNA sequence for neutrophil chemotactic factor. Blots were stringency washed 
and autoradiographs were quantified by laser densitometry. Equivalent amounts 
of total RNA load per gel lines were assessed by monitoring 28s and 18s rRNA. 
RESULTS 
As shown by the Northern blot analysis data in Fig. 1, unstimulated human 
synovial cells did not constituitively express mRNA for IL-8 (columns A, D, F, I, 
M). Laser densitometry of the Northern blots demonstrated that significant levels 
of IL-8 mRNA were induced by small amounts (1400 U> of IL-la (CO~UIIXIS B, E, G, 
J> or IL-18 (column N). 
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I - Media alone 
94 J - IL-la 
R.A. K - IL-la+ EPA 
L - IL-la+ DGLA 
M - Media alone 
E.P. 
#5 
N - IL-10 
R.A. 0 - IL-10 + DGLA 
P - IL-lp+ EPA 
Q - IL-lp+ AA 
Fieure 1. JXorthern blot analvsis of IL-8 mRNA e D ess’on bv human svnovial 
cells stimulated with IL-la or IL-Q. (Insert, Top; ki:als were quantified by 
laser densitometry of the autoradiographs (bar graph). 
OA: Synovium from osteoarthritis patient. RA: Synovium from rheumatoid 
arthritis patient. DGLA: dihomogammalinolenic acid; AA: arachidonic acid; 
EPA: eicosapentaenoic acid. Fatty acids (10 ug/ml) added to synovial cells in 
culture during 8 hr stimulation with IL-la or IL-18. 
Similarly, human synovial cells do not constituitively express mRNA for 
MCP (Fig. 2). However, examination of the Northern blot analyses in Fig. 2, 
indicates that stimulation of these cells with IL-la (columns B, E, G, J) or IL-113 
(column N) induces gene expression for MCP (Fig. 2). 
Because dihomogamma linolenic acid (DGLA), an unsaturated fatty acid 
precursor to monooenoic prostaglandins and allied compounds, selectively 
suppresses growth of IL-l stimulated human synovial cells in culture (9) and of 
inflammation and joint tissue injury in animal models (lo), we studied its effects 
on expression of mRNA for IL-S and MCP. Neither DGLA (10 vg/ml) nor the other 
prostaglandin precursor fatty acids (arachidonic acid, eicosapentaenoic acid) 
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F - Media alone E.P. N - IL-1 
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R.A. H - IL-la+ DGLA P - IL-lp+ EPA 
Q - IL-la+ AA 
Fipure 2. Northern blot analvsis of MCP ITIRNA exDres&m bv human svno+J 
cells stimulated with IL-la or I D L-l . Abbreviations and methods as in text and in 
Figure 1. 
altered gene expression of IL-S (Fig. 1, columns C, H, K, L, 0, P, Q) or MCP (Fig. 2, 
same columns). 
Quantitative laser densitometry analysis of the Northern blots indicate that 
IL-1 stimulated synovial cells from both osteoarthritis (OA) and RA patients 
exhibited similar mRNA expression of IL-S (Fig. 1) and MCP (Fig. 2). Synovium 
from the OA patients was hyperplastic and inflamed. 
DISCUSSION 
Rheumatoid synovitis likely results from a cellular immune response to an 
antigen present in synovium or articular cartilage. As a result of a specific 
immune response, a series of cytokine mediated reactions are set in motion which 
lead to the mobilization of PMN and of T and B lymphocytes and monocytes whose 
immunological specificity is largely polyclonal. 
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The ability of macrophage derived IL-1 and IL-8 to act as chemotactic agents 
for lymphocytes (11,12) provides a stimulus for the movement of lymphocytes 
toward an inflammatory focus. The data presented here indicate that IL-1 has the 
capacity to stimulate production by synovial cells of IL-8 which could then attract 
PMN and lymphocytes to the inflamed joint space. 
DR+ macrophages are present in rheumatoid synovial tissue. It has been 
suggested (13) that these cells may represent a specific population, derived from 
monocytes, that move from the postcapillary venule toward the hyperplastic 
synovium by virtue of monocyte chemotactic factors released by activated synovial 
lining cells. The observations presented here that IL-l does in fact stimulate 
human synovial cells to express the gene for monocyte chemotactic protein, lends 
support to this theory. 
Streiter et al. found gene expression for individual chemotactic cytokines to 
be cell and stimulus specific (4,5). Thus, LPS stimulated phagocytic cells 
(monocytes, PMN, alveolar macrophages), as well as endothelial cells, express 
mRNA for IL-8 but only LPS stimulated endothelial cells express mRNA for MCP. 
In contrast, human B lymphocytes treated with LPS fail to express IL-8 mRNA but 
appear to synthesize a monocyte chemotactic factor in response to LPS. It is 
therefore of importance that IL-1 stimulated human synovial cells express mRNA 
for both IL-8 and MCP. The findings emphasize the central role of the synovial 
lining cells in facilitating development of chronic inflammatory arthritis. 
Experimental evidence indicates that selected polyunsaturated fatty acids 
have antiinflammatory effects. Chief among these is DGLA, which suppresses 
synovial cell proliferation in vitro (9) and inflammation and joint tissue injury in 
experimental animal models (10). DGLA also suppresses IL-2 production by 
stimulated human peripheral blood mononuclear cells (14) and reduces IL-2 
driven human T lymphocyte proliferation (15). Preliminary unpublished studies 
in our laboratory indicate that DGLA administered in uiuo or added to cells in vitro 
reduces TNF production by stimulated human peripheral blood mono&es. 
Nonetheless, neither DGLA nor other prostaglandin precursor fatty acids 
(arachidonate and EPA) are able to suppress the expression of IL-8 or MCP 
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mRNA, findings which may further define the selectivity of fatty acids in 
regulation of immune responses. 
In the studies presented here, both OA and RA synovial cells express the 
genes for IL-8 and MCP when stimulated with IL-l. The findings suggest that 
production of the chemotactic factors is not driven solely by specific antigen. 
Rather, by this mechanism, synovial cells appear able to amplify an ongoing 
inflammatory response. 
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